| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.22 | 8e-06 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-05 |